Combretastatin A4, 98.0%, 25mg

1,3,5-Tri(4-carboxyphenyl)benzene, 98%, 25g

1,4-Bis(isopropylamino)anthracene-9,10-dione, 98%, 100g

N-(1-Pyrenyl)maleimide, 99.0%, 250mg

1,3,5-Tris(4'-fluorobiphenyl-4-yl)benzene>95.0%(HPLC)200mg

3-Benzyl-7-(phenylsulfonyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane, 95%, 1g

3-(4-Bromophenyl)-3-oxo-propionic acid ethylester, 95.0%, 10g

2,2-Dimethylpentanoic acid, 95.0%, 1g

Methyl 2-fluorobenzoate, 98.0%, 500g

3H-Benzo[d]imidazol-4-amine, 95.0%, 1g

2-Aminobenzothiazole, 95.0%, 1g

2-(2-Azidoethoxy)ethyl 4-methylbenzenesulfonate, 98%, 5g

(R)-(+)-2-(Methoxymethyl)-1-pyrrolidinecarboxaldehyde>98.0%(GC)1g